Read and Download eBook Full
Author: Ling Zhang
Publisher: Frontiers Media SA
Published: 2023-03-16
Total Pages: 236
ISBN-13: 2832502342
DOWNLOAD EBOOKAuthor: Shao Li
Publisher: Springer Nature
Published: 2021-09-29
Total Pages: 480
ISBN-13: 9811607532
DOWNLOAD EBOOKThis book introduces “network pharmacology” as an emerging frontier subject of systematic drug research in the era of artificial intelligence and big data. Network Pharmacology is an original subject of fusion system biology, bioinformatics, network science and other related disciplines. It emphasizes on starting from the overall perspective of the system level and biological networks, the analysis of the laws of molecular association between drugs and their treatment objects, reveals the systematic pharmacological mechanisms of drugs, and guides the research and development of new drugs and clinical diagnosis and treatment. After it was proposed, network pharmacology has been paid attention by researchers, and it has been rapidly developed and widely used. In order to systematically reveal the biological basis of diagnosis and treatment in traditional Chinese medicine and modern medicine, we proposed a new concept of "network target" for the first time, which has become the core theory of "network pharmacology". The core principle of a network target is to construct a biological network that can be used to decipher complex diseases. The network is then used as the therapeutic target, to which multicomponent remedies are applied. This book mainly includes four parts: 1) The concept and theory of network pharmacology; 2) Common analysis methods, databases and software in network pharmacological research; 3) Typical cases of traditional Chinese medicine modernization and modern drug research based on network pharmacology; 4) Network pharmacology practice process based on drugs and diseases.
Author: Singh, Ajeet
Publisher: IGI Global
Published: 2020-02-21
Total Pages: 442
ISBN-13: 1799820955
DOWNLOAD EBOOKA vast majority of the world’s population lacks access to essential medicines and the provision of safe healthcare services. Medicinal plants and herbal medicines can be applied for pharmacognosy, or the discovery of new drugs, or as an aid for plant physiology studies. In recent years, there has been increased interest in the search for new chemical entities and the expression of resistance of many drugs available in the market has led to a shift in paradigm towards medicinal research. Herbal treatments, the most popular form of folk medicine, may become an important way of increasing access to healthcare services. Advanced Pharmacological Uses of Medicinal Plants and Natural Products provides emerging research exploring the theoretical and practical aspects of drug discovery from natural sources that allow for the effective treatment of human health problems without any side effects, toxicity, or drug resistance. Featuring coverage on a broad range of topics such as ethnobotany, therapeutic applications, and bioactive compounds, this book is ideally designed for pharmacologists, scientists, ethnobotanists, botanists, health researchers, professors, industry professionals, and health students in fields that include pharmaceutical drug development and discovery.
Author: World Health Organization
Publisher: World Health Organization
Published: 2019-05-16
Total Pages: 228
ISBN-13: 9241515430
DOWNLOAD EBOOKThis report is structured in five parts: national framework for traditional and complementary medicine (T&CM); product regulation; practices and practitioners; the challenges faced by countries; and finally the country profiles. Apart from the section on practices and practitioners the report is consistent with the format of the report of the first global survey in order to provide a useful comparison. The section on practices and practitioners which covers providers education and health insurance is a new section incorporated to reflect the emerging trends in T&CM and to gather new information regarding these topics at a national level. All new information received has been incorporated into individual country profiles and data graphs. The report captures the three phases of progress made by Member States; that is before and after the first WHO Traditional Medicine Strategy (1999?2005) from the first global survey to the second global survey (2005?2012) and from the second survey to the most recent timeline (2012?2018).
Author: Ramarao Poduri
Publisher: Springer Nature
Published: 2021-02-15
Total Pages: 522
ISBN-13: 9811555346
DOWNLOAD EBOOKThis book describes the processes that are involved in the development of new drugs. The authors discuss the history, role of natural products and concept of receptor interactions with regard to the initial stages of drug discovery. In a single, highly readable volume, it outlines the basics of pharmacological screening, drug target identification, and genetics involved in early drug discovery. The final chapters introduce readers to stem therapeutics, pharmacokinetics, pharmacovigilance, and toxicological testing. Given its scope, the book will enable research scholars, professionals and young scientists to understand the key fundamentals of drug discovery, including stereochemistry, pharmacokinetics, clinical trials, statistics and toxicology.
Author: J. Mulzer
Publisher: Springer Science & Business Media
Published: 2013-04-17
Total Pages: 363
ISBN-13: 3662040425
DOWNLOAD EBOOKNatural Products have been important sources of useful drugs from prehistoric times to the present. This book gives an overview about this field and provides important recent contributions to the discovery of new drugs generated by research on natural products. Total synthesis of natural products with interesting biological activities is paving the way for the preparation of new and improved analogs. The methods of combinatorial chemistry permit the selection of the best drug from a large number of candidates. Beyond synthesis and evaluation of organic molecules a number of new bioorganic methods are coming to the fore and will be discucced in this isue of the ERnst schering Research Foundation workshop proceedings.
Author: Neil T. Choplin
Publisher: CRC Press
Published: 2014-06-04
Total Pages: 365
ISBN-13: 1482209217
DOWNLOAD EBOOKGlaucoma affects all age groups and is a leading cause of blindness worldwide. It is imperative that practicing clinicians and surgeons recognize both primary and secondary glaucoma as well as cases of glaucoma associated with other disorders. Atlas of Glaucoma, Third Edition provides an in-depth review and analysis of the management of glaucoma and discusses research advancements that have resulted in the latest therapies. See What's New in the Third Edition: The influence of the cornea on intraocular pressure measurements and new devices designed to account for this Spectral domain optical coherence tomography (OCT) New statistical methods for tracking rates of progression New medications released since 2006 New chapter on trabecular bypass surgery Additional topics include: Classification of glaucoma Measurement of intraocular pressure and gonioscopy The optic nerve Psychophysical and electrophysiological testing in glaucoma Primary open-angle, secondary open-angle, and angle closure glaucomas Ocular blood flow and metabolism Medical therapy and surgical treatments Aqueous shunts Combined cataract and glaucoma surgery Treatment of developmental glaucoma This colorful atlas contains detailed captions for each illustration, making it ideal for teaching purposes as well as a reference for the practicing ophthalmologist. Glaucoma encompasses a wide variety of clinical entities, clinical findings, diagnostic techniques, and treatment options. This book presents a vast assemblage of insight from internationally recognized experts.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2017-09-28
Total Pages: 483
ISBN-13: 0309459575
DOWNLOAD EBOOKDrug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: Paul M. Dewick
Publisher: John Wiley & Sons
Published: 2002-01-03
Total Pages: 524
ISBN-13: 9780471496410
DOWNLOAD EBOOKThis guide covers classes of natural products in medicine, whether derived from plants, micro-organisms or animals. Structured according to biosynthetic pathway, it is written from a chemistry-based approach.
Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
Published: 2010
Total Pages: 728
ISBN-13:
DOWNLOAD EBOOKThis report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
